TN: 2.4% Drug Samples Fail In Quality Check In 2022

CHENNAI : In 2022, the Directorate of Drugs Control Tamil Nadu tested 12,959 samples of medicines for quality in which about 317 were found to be of substandard quality.

At least 4,000 more samples were tested when compared to 2021. There were 8,900 samples tested in 2021 when about 313 were found to be of substandard quality. At least 2.4% of all samples failed the quality check in 2022, while it was 3.5% in 2021.

Officials from the State Health Department said, “There’s a strict vigil on drug manufacturers, medical representatives and pharmacists to ensure that no drugs that fail the quality check are being sold or manufactured.”

Over 5,000 regional units were inspected for testing samples of drugs and medical products to check them for quality. “Regional officers make sure to collect samples from manufacturing units, medical stores, pharmacies, and hospitals. The drug misuse and abuse has also been curtailed,” said drug controller Dr PV Vijayalakshmi.

She added that officials under the supervision of the directorate were on field inspection even during the pandemic, and had to ensure that there was no misuse or abuse of essential drugs.

“Tablets like paracetamol, sanitisers and testing kits were checked. We’ve been able to control the distribution of paracetamol and ensured that it met the quality standards. Even during enquiry via the 104-helpline, we’ve clarified their concerns on the medicines and its right quality,” stated Dr Vijayalakshmi.

  • Related Posts

    Cancer drug makers seek 50% price hike as platinum surge hits production viability

    Mumbai | Delhi: Manufacturing of cancer medicines such as carboplatin, oxaliplatin and cisplatin has become unviable due to a surge in the price of platinum, a critical component in these…

    CDRI’s new research hub in Lucknow to facilitate innovation in drug discovery & development

    Lucknow:  Marking 70 years of its inception, the Central Drug Research Institute (CDRI) in Lucknow launched a new and advanced research facility called Common Research and Technology Development Hub (CRTDH).…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Cancer drug makers seek 50% price hike as platinum surge hits production viability

    Cancer drug makers seek 50% price hike as platinum surge hits production viability

    CDRI’s new research hub in Lucknow to facilitate innovation in drug discovery & development

    CDRI’s new research hub in Lucknow to facilitate innovation in drug discovery & development

    Delhi Police busts racket diverting govt-supplied medicines for private sale; 3 held

    Delhi Police busts racket diverting govt-supplied medicines for private sale; 3 held

    Niti Aayog & DPIIT Decriminalize Med Device Penalties for Ease of Business

    Niti Aayog & DPIIT Decriminalize Med Device Penalties for Ease of Business

    Laser rescued an Imperiled Food Pipe in Sir Ganga Ram Hospital

    Laser rescued an Imperiled Food Pipe in Sir Ganga Ram Hospital

    Centre gives custom cushion to supply strained Pharma, MedTech manufacturers

    Centre gives custom cushion to supply strained Pharma, MedTech manufacturers